SOC2011
20 Apr 2022
SOC2011
NCT04677855
A Phase I Study of PCUR-101 in Combination With Androgen Directed Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
Pellficure Pharmaceuticals
Cancer Type | Prostate |
---|---|
Trial Type | Treatment |
Phase | Phase I |
Age Range | 18 years and older |
Sex | Male |
Tumour Stream | - |
Cancer Stage | Metastatic or Widespread |
Anticipated Start Date | 2021-03-30 |
Anticipated End Date | 2023-06-01 |
Hospital | Southern Oncology Clinical Research Unit |
---|---|
Clinical Trial Coordinator | Meggan O'Riley |
Meggan.ORiley@socru.org.au | |
Phone | 0491 679 039 |
Principal Investigator | Dr Sina Vatandoust |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs